Pharma company Lupin Ltd said its US subsidiary Lupin Pharmaceuticals Inc received US Food and Drug Administration (USFDA) approval for its Suprax (Cefixime) chewable tablets of 100mg, 150mg and 200mg strength.
Suprax is a drug to treat urinary tract infections in children, the company said in a statement.
On Tuesday, Lupin shares ended flat at Rs444 on the Bombay Stock Exchange, while the benchmark Sensex 0.1% down at 20,345 points.
Inside story of the National Stock Exchange’s amazing success, leading to hubris, regulatory capture and algo scam
Fiercely independent and pro-consumer information on personal finance.
1-year online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
30-day online access to the magazine articles published during the subscription period.
Access is given for all articles published during the week (starting Monday) your subscription starts. For example, if you subscribe on Wednesday, you will have access to articles uploaded from Monday of that week.
This means access to other articles (outside the subscription period) are not included.
Articles outside the subscription period can be bought separately for a small price per article.
Fiercely independent and pro-consumer information on personal finance.
Complete access to Moneylife archives since inception ( till the date of your subscription )
